
|Articles|August 16, 2018
Risuteganib for the treatment of DME
Advertisement
Peter Kaiser, MD, shares how risuteganib (Luminate, Allegro) can help with the treatment of DME when anti-VEGF treatment isn't a viable option. He presented his research in Vancouver, British Columbia, during the 2018 annual meeting of the American Society of Retina Specialists.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Why ST-100 is expanding from dry eye into corneal wound healing
2
Eichenbaum Acorns: Building the private academic model with Jeffrey S. Heier, MD
3
ONL Therapeutics completes enrollment in Phase 2 GALAXY trial for geographic atrophy
4
Water-soluble CBD eye drops lower IOP and dampen corneal sensitivity in glaucoma mouse model
5
















